CTRI/2022/09/045216
Active, not recruiting
未知
A prospective, Multicentric, cross-sectional study to evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Sponsor
- Dr Reddys Laboratories Ltd
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\-Patients of either sex aged 18 years and above.
- •2\-Willing and able to sign Data Disclosure consent form.
- •3\-Patients with clinical diagnosis of Type 2 Diabetes Mellitus
Exclusion Criteria
- •As this is cross\-section study, exclusion criterias will not be applicable for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the Clinical Performance of the ColoSTAT Diagnostic for colorectal cancer biomarkersACTRN12619000301167Vision Tech Bio Pty Ltd815
Not yet recruiting
Not Applicable
Safety of Antibiotic (Faropenem) in Pediatric Patients with Respiratory Tract Infections (RTIs), Or Urinary Tract Infection (UTIHealth Condition 1: J988- Other specified respiratory disordersHealth Condition 2: N390- Urinary tract infection, site notspecifiedCTRI/2024/01/061255Alkem Laboratories Limited
Recruiting
Not Applicable
A multi-center, cross-section, retrospectivestudy of TCM symptome characteristics of atherosclerotic myocardial infarctioAtherosclerotic myocardial infarctionITMCTR2200005906Zhejiang Chinese Medical University
Completed
Not Applicable
Comparison of SIRS criteria and qSOFA score for identifying sepsis in the Emergency DepartmentNL-OMON23850none750
Completed
Not Applicable
An observational multicenter study comparing Tenecteplase assisted Percutaneous Coronary Intervention (PCI) versus primary PCI in Indian patients with ST elevation Myocardial InfarctioHealth Condition 1: null- Patients with acute STEMI who are to be treated with primary PCI/pharmacoinvasive therapy within 12 hours of symptoms onset will be included.CTRI/2011/08/001950STEMI India Charitable Trust200